Ageism in Indonesia’s national covid-19 vaccination programme
Author:
Publisher
BMJ
Subject
General Engineering
Reference10 articles.
1. Equitable global access to coronavirus disease 2019 vaccines
2. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
3. Kompasiana. It turns out that the Sinovac covid-19 vaccine is only for ages 18-59 years. [Indonesian]. 2020. www.kompasiana.com/editanto/5fd2e8c58ede484ac513ae42/ternyata-vaksin-covid-19-sinovac-hanya-untuk-usia-18-59-tahun?page=all.
4. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
5. Sinovac-covid-19 vaccine: President Jokowi is aiming to vaccinate Indonesians in January 2021. [Indonesian] 24 July 2021. www.bbc.com/indonesia/indonesia-53482828.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Vulnerable, Heroic … or Invisible? Representations Versus Realities of Later Life in Indonesia;Progress in Development Studies;2023-10
2. Social Work Leadership for Patient Safety;Social Work - Perspectives on Leadership and Organisation;2023-03-22
3. Age discrimination, the right to life, and COVID‐19 vaccination in countries with limited resources;Journal of Social Issues;2022-09-30
4. Guiding equitable prioritisation of COVID-19 vaccine distribution and strategic deployment in South Africa to enhance effectiveness and access to vulnerable communities and prevent waste;South African Medical Journal;2022-02-01
5. Biotechnological Strategies in the Intervention and Treatment of COVID-19;Frontiers of COVID-19;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3